Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Nabeshima

Showing results (81-90 of 82) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 82 results.
International Journal of Clinical Pharmacology Research|August 3, 2005
Interferon-beta induction/interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis CK I Kim, N Sasase, M Taniguchi, et al.
Journal of Clinical Pharmacy and Therapeutics|September 9, 2006
2'-,5'-Oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis CK-I Kim, S-R Kim, N Sasase, et al.
Pageof 9

Showing results (81-90 of 82) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 82 results.
International Journal of Clinical Pharmacology Research|August 3, 2005
Interferon-beta induction/interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis CK I Kim, N Sasase, M Taniguchi, et al.
Journal of Clinical Pharmacy and Therapeutics|September 9, 2006
2'-,5'-Oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis CK-I Kim, S-R Kim, N Sasase, et al.
Pageof 9